Hou Y - Search Results

1

Explorations of novel MDR-related hub genes and the potential roles TRIM9 played in drug-resistant hepatocellular carcinoma.

Xiao L, Lu Z, Fang H, Zhou Y, Che W, Zhang W, Bai X, Zhang D, Nie G, Cao H, Hou Y. Xiao L, et al. Among authors: hou y. Int J Biol Macromol. 2024 Dec 18;290:138949. doi: 10.1016/j.ijbiomac.2024.138949. Online ahead of print. Int J Biol Macromol. 2024. PMID: 39706432

2

A novel targeted delivery system for drug-resistant hepatocellular carcinoma therapy.

Xiao L, Hou Y, He H, Cheng S, Hou Y, Jin H, Song X, Nie G, Hou Y. Xiao L, et al. Among authors: hou y. Nanoscale. 2020 Aug 20;12(32):17029-17044. doi: 10.1039/d0nr01908a. Nanoscale. 2020. PMID: 32780053

3

Development of an efficient liposomal DOX delivery formulation for HCC therapy by targeting CK2α.

Zhao R, Cheng S, Bai X, Zhang D, Fang H, Che W, Zhang W, Zhou Y, Duan W, Liang Q, Xiao L, Nie G, Hou Y. Zhao R, et al. Among authors: hou y. Biotechnol J. 2024 Apr;19(4):e2400050. doi: 10.1002/biot.202400050. Biotechnol J. 2024. PMID: 38651271

4

The VEGFA-Induced MAPK-AKT/PTEN/TGFβ Signal Pathway Enhances Progression and MDR in Gastric Cancer.

Fang H, Zhou Y, Bai X, Che W, Zhang W, Zhang D, Chen Q, Duan W, Nie G, Hou Y. Fang H, et al. Among authors: hou y. Genes (Basel). 2024 Sep 27;15(10):1266. doi: 10.3390/genes15101266. Genes (Basel). 2024. PMID: 39457390 Free PMC article.

5

The roles EpCAM plays to enhance the malignancy of gastric cancer.

Zhao X, Zhao R, Feng Y, Qiu Z, Bai X, Zhang D, Zhou Y, Fang H, Liu N, Chen L, Jia C, Yuan Y, Li X, Duan W, Nie G, Hou Y. Zhao X, et al. Among authors: hou y. J Cancer Res Clin Oncol. 2023 Sep;149(11):8495-8505. doi: 10.1007/s00432-023-04767-2. Epub 2023 Apr 24. J Cancer Res Clin Oncol. 2023. PMID: 37095412

6

Selection and identification of a specific peptide binding to ovarian cancer cells from a phage-displayed peptide library.

Gao Q, Chen L, Jia C, Yuan Y, Li X, Lu Z, Feng Y, Zhao R, Zhao X, Wang Y, Cheng S, Zhang C, Xu J, Shu Z, Duan W, Nie G, Xiao L, Hou Y. Gao Q, et al. Among authors: hou y. Biotechnol Lett. 2022 Aug;44(8):951-960. doi: 10.1007/s10529-022-03263-w. Epub 2022 Jun 30. Biotechnol Lett. 2022. PMID: 35771408

7

Roles of N-terminal Annexin A2 phosphorylation sites and miR-206 in colonic adenocarcinoma.

Xiao L, Jin H, Duan W, Hou Y. Xiao L, et al. Among authors: hou y. Life Sci. 2020 Jul 15;253:117740. doi: 10.1016/j.lfs.2020.117740. Epub 2020 May 3. Life Sci. 2020. PMID: 32376265

8

LEF1 Enhances the Progression of Colonic Adenocarcinoma via Remodeling the Cell Motility Associated Structures.

Xiao L, Zhang C, Li X, Jia C, Chen L, Yuan Y, Gao Q, Lu Z, Feng Y, Zhao R, Zhao X, Cheng S, Shu Z, Xu J, Duan W, Nie G, Hou Y. Xiao L, et al. Among authors: hou y. Int J Mol Sci. 2021 Oct 8;22(19):10870. doi: 10.3390/ijms221910870. Int J Mol Sci. 2021. PMID: 34639214 Free PMC article.

9

ANXA2 enhances the progression of hepatocellular carcinoma via remodeling the cell motility associated structures.

Shi H, Xiao L, Duan W, He H, Ma L, Da M, Duan Y, Wang Q, Wu H, Song X, Hou Y. Shi H, et al. Among authors: hou y. Micron. 2016 Jun;85:26-33. doi: 10.1016/j.micron.2016.03.008. Epub 2016 Mar 31. Micron. 2016. PMID: 27060670

10

The APEX1/miRNA-27a-5p axis plays key roles in progression, metastasis and targeted chemotherapy of gastric cancer.

He H, Song F, Gao Q, Lu Z, Yuan Y, Li X, Chen L, Jia C, Yang R, Yang J, Duan W, Hou Y. He H, et al. Among authors: hou y. Int J Pharm. 2021 Apr 15;599:120446. doi: 10.1016/j.ijpharm.2021.120446. Epub 2021 Mar 4. Int J Pharm. 2021. PMID: 33675923

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,608 results

Search Page

Filters